Deciphering the mitochondria–gut microbiota axis in irritable bowel syndrome: pathogenic insights and therapeutic frontiers

Abstract Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder involving multiple pathogenic mechanisms. Gut microbiota dysbiosis and mitochondrial dysfunction are key drivers of IBS, as they weaken the intestinal barrier, promote inflammation, and alter metabolism. Howeve...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lifang Zeng, Wenpeng Zhou
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2026-03-01
Sarja:	Journal of Translational Medicine
Aiheet:	Mitochondria Gut microbiota Irritable bowel syndrome Pathogenesis Therapy
Linkit:	https://doi.org/10.1186/s12967-026-07894-9
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!